EXAS vs PG · rev $2.76B vs P/E 25, rev $84.28B
EXACT Sciences Corporation (EXAS) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
EXAS currently screens at market cap $20.03B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the EXAS and PG stock pages for the full models.
Not investment advice.